Hemogenyx Pharmaceuticals Plc

HOPHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$6-$7-$4-$5
Dep. & Amort.$1$1$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$0$0$0$0
Change in WC$0-$1$0$0
Other Non-Cash$0$1$1$2
Operating Cash Flow-$4-$6-$3-$3
Investing Activities
PP&E Inv.-$0-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$0-$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0-$1
Financing Activities
Debt Repay.-$1$0$0$9
Stock Issued$5$5$0$12
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1-$1-$0-$0
Financing Cash Flow$3$4-$0$9
Forex Effect-$0$0-$1-$0
Net Chg. in Cash-$1-$1-$4$5
Supplemental Information
Beg. Cash$1$3$7$2
End Cash$0$1$3$7
Free Cash Flow-$4-$6-$3-$3